Rivaroxaban improves hidden blood loss, blood transfusion rate and reduces swelling of the knee joint in knee osteoarthritis patients after total knee replacement

Osteoarthritis (OA) is the third most common diagnosis made by general practitioners in older patients. The purpose of the current study is to investigate effects rivaroxaban had on both hidden blood loss and blood transfusion rate (BTR) in patients with knee OA (KOA) after going through a total kne...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yi-Min, Liu, Jian-Yong, Sun, Xue-Dong, Zhang, Miao, Liu, Xiao-Guang, Chen, Xiu-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200479/
https://www.ncbi.nlm.nih.gov/pubmed/30290638
http://dx.doi.org/10.1097/MD.0000000000012630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200479/
https://www.ncbi.nlm.nih.gov/pubmed/30290638
http://dx.doi.org/10.1097/MD.0000000000012630

Ejemplares similares